Reactions to tetanus toxoid. 1973

W G White, and G M Barnes, and E Barker, and D Gall, and P Knight, and A H Griffith, and R M Morris-Owen, and J W Smith

In a factory population the occurrence of reactions to tetanus toxoid was recorded after 6740 injections. The incidence of general reactions was 0.3% and of local reactions 2.6%. The local reaction rate to the first injection of the basic immunization course was 0.9%, to the second injection 2.7%, and to the third injection 7.4%. To booster injections the rate was 1.6%. The local reaction rate was appreciably higher in women than in men - 14.4% and 5.7% respectively in the case of the third injection - and the incidence among women increased with age.Tetanus vaccine containing 10 Lf of toxoid caused fewer reactions than one containing 20 Lf, but a reduction in the content of aluminium adjuvant did not affect the reaction rate.Almost all reactors were found to have a satisfactory serum antitoxin concentration at the time of the reaction or developed a satisfactory immunity within 1-6 months.Skin tests were made in 32 hypersensitive patients. Neither the diluent, thiomersal preservative, nor the culture medium appeared to be responsible for hypersensitivity. The degree of hypersensitivity elicited by a special highly purified toxoid was only very slightly less than that elicited by the commercially pure toxoid. It is suggested that reactions are largely due to the toxoid antigen itself rather than to impurities or other components of the vaccine.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004342 Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. Allergy, Drug,Hypersensitivity, Drug,Drug Allergy,Allergies, Drug,Drug Allergies,Drug Hypersensitivities,Hypersensitivities, Drug
D004890 Erythema Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes. Erythemas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

W G White, and G M Barnes, and E Barker, and D Gall, and P Knight, and A H Griffith, and R M Morris-Owen, and J W Smith
February 1966, Southern medical journal,
W G White, and G M Barnes, and E Barker, and D Gall, and P Knight, and A H Griffith, and R M Morris-Owen, and J W Smith
September 1983, JAMA,
W G White, and G M Barnes, and E Barker, and D Gall, and P Knight, and A H Griffith, and R M Morris-Owen, and J W Smith
December 1969, Journal of the Irish Medical Association,
W G White, and G M Barnes, and E Barker, and D Gall, and P Knight, and A H Griffith, and R M Morris-Owen, and J W Smith
May 1994, JAMA,
W G White, and G M Barnes, and E Barker, and D Gall, and P Knight, and A H Griffith, and R M Morris-Owen, and J W Smith
October 1968, The Journal of pediatrics,
W G White, and G M Barnes, and E Barker, and D Gall, and P Knight, and A H Griffith, and R M Morris-Owen, and J W Smith
January 1982, JAMA,
W G White, and G M Barnes, and E Barker, and D Gall, and P Knight, and A H Griffith, and R M Morris-Owen, and J W Smith
January 1974, British medical journal,
W G White, and G M Barnes, and E Barker, and D Gall, and P Knight, and A H Griffith, and R M Morris-Owen, and J W Smith
January 1967, JAMA,
W G White, and G M Barnes, and E Barker, and D Gall, and P Knight, and A H Griffith, and R M Morris-Owen, and J W Smith
February 1973, Lancet (London, England),
W G White, and G M Barnes, and E Barker, and D Gall, and P Knight, and A H Griffith, and R M Morris-Owen, and J W Smith
July 1965, Archives of environmental health,
Copied contents to your clipboard!